{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:43:31Z","timestamp":1792424611509,"version":"4.5.0"},"reference-count":49,"publisher":"American Medical Association (AMA)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Intern Med"],"abstract":"\n Importance<\/jats:title>\n Nontargeted hepatitis C virus (HCV) screening in emergency departments (EDs) has been demonstrated to identify more patients with HCV than targeted screening. Cost-effectiveness is key to strategy selection; however, the cost-effectiveness of these strategies in EDs remains unknown.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To compare clinical outcomes and cost-effectiveness of 2 novel ED-based HCV screening strategies with no ED HCV screening.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n In this economic evaluation study, a cohort of individuals presenting to the ED in the US was simulated with data from the Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes for Hepatitis C Screening (DETECT Hep C) trial using the Hepatitis C Cost-Effectiveness (HEP-CE) model from a health sector perspective. Using data from EDs at Denver Health Medical Center, Johns Hopkins Hospital, and the University of Mississippi Medical Center, 3 strategies were simulated over a lifetime horizon, including (1) no ED HCV screening, (2) targeted HCV screening, and (3) nontargeted HCV screening. Data were collected from November 2019 to August 2022 and analyzed from December 2021 to July 2026.<\/jats:p>\n <\/jats:sec>\n \n Exposure<\/jats:title>\n HCV screening in the ED.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n The primary outcomes were remaining life expectancy, quality-adjusted life-years (QALYs), incremental cost-effectiveness ratios (ICERs), and costs (2024 US dollars). An annual discount rate of 3% was applied to future costs and benefits when calculating ICERs. An ICER of less than $100\u202f000 per QALY gained was considered cost-effective.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n A simulated cohort with a total of 500 million individuals (mean [SD] age, 46.3 [17.2] years; 264.4 million male [52.88%]) were included in this analysis. Nontargeted HCV screening yielded the best clinical and cost-effectiveness outcomes in the base case cohort, with 65.89% of infections being cured, a discounted cost of $214\u202f465, discounted quality-adjusted life expectancy of 15.8723 QALYs, and an ICER of $12\u202f820 per QALY gained. Compared with nontargeted HCV screening, no ED HCV screening and targeted HCV screening, respectively, had fewer infections cured (65.60% and 65.88%), lower QALYs (15.8717 QALYs and 15.8721 QALYs), and similar discounted costs ($214\u202f467 and $214\u202f462). Absolute benefits appeared narrow because over 90% of those screened did not have HCV; however, benefits were clear among those living with HCV infection.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n Results of this economic evaluation study suggest that nontargeted HCV screening was cost-effective when compared with no HCV screening or targeted HCV screening in the ED. Implementing routine nontargeted HCV screening in emergency departments provides good economic value and could be an important pillar of HCV elimination.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamainternmed.2026.5163","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:30:22Z","timestamp":1792423822000},"source":"Crossref","is-referenced-by-count":0,"title":["Cost-Effectiveness of HCV Screening in Emergency Departments Using DETECT Hep C Trial Results"],"prefix":"10.1001","author":[{"given":"Larsan M. W.","family":"Czoty","sequence":"first","affiliation":[{"name":"Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Munroe","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Stewart","sequence":"additional","affiliation":[{"name":"Harvard John A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Haukoos","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Denver Health, Denver, Colorado"},{"name":"Department of Emergency Medicine, University of Colorado School of Medicine, Aurora"},{"name":"Department of Epidemiology, Colorado School of Public Health, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Rowan","sequence":"additional","affiliation":[{"name":"Public Health Institute at Denver Health, Denver, Colorado"},{"name":"Division of Infectious Diseases, Denver Health, Denver, Colorado"},{"name":"Division of Infectious Diseases, University of Colorado School of Medicine, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Hopkins","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Denver Health, Denver, Colorado"},{"name":"Department of Emergency Medicine, University of Colorado School of Medicine, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Rothman","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Galbraith","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of Mississippi Medical Center, Jackson"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hsiang","family":"Hsieh","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolynn","family":"Lyle","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Denver Health, Denver, Colorado"},{"name":"Department of Emergency Medicine, University of Colorado School of Medicine, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Gravitz","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Denver Health, Denver, Colorado"},{"name":"Department of Emergency Medicine, University of Colorado School of Medicine, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin F.","family":"Kamis","sequence":"additional","affiliation":[{"name":"Public Health Institute at Denver Health, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A. E.","family":"White","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Alameda Health System, Wilma Chan Highland Hospital, Oakland, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Lyons","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward M.","family":"Gardner","sequence":"additional","affiliation":[{"name":"Public Health Institute at Denver Health, Denver, Colorado"},{"name":"Division of Infectious Diseases, Denver Health, Denver, Colorado"},{"name":"Division of Infectious Diseases, University of Colorado School of Medicine, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alia A.","family":"Al-Tayyib","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Colorado School of Public Health, Aurora"},{"name":"Public Health Institute at Denver Health, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison L.","family":"Sabel","sequence":"additional","affiliation":[{"name":"Department of Patient Safety and Quality, Denver Health, Denver, Colorado"},{"name":"Department of Biomedical Informatics, University of Colorado School of Medicine, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Wyles","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of Colorado School of Medicine, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Baptiste","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin P.","family":"Linas","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Infectious Diseases, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake R.","family":"Morgan","sequence":"additional","affiliation":[{"name":"Department of Health Law, Policy, and Management, Boston University School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"DETECT Hep C Trial Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Adler","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musheng","family":"Alishahi","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Avornu","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Barinas","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Becerra","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Becerra-Ashby","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Bellamy","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Bot","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Boyle","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annetta M.","family":"Bracey","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dante","family":"Brown","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meggan","family":"Bucossi","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Camacho","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Cupelo","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna","family":"Curbeam","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaby","family":"Dashler","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie Anne","family":"De Gruiter","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Doyle","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Eichler","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Gardner","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Hill","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauren","family":"Henley","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Henry","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Higgins","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Houk","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyah","family":"Johnson","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Jones","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Joseph","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabor","family":"Kelen","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Kile","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Kurzdorfer","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J.","family":"Lewis","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Liebl","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Lundin","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Maliszewski","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"McCormick","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"McGoey","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"McKenzie","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Minturn","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Murray","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna","family":"Myer","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenddra","family":"Neumann","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Niell","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cole","family":"Ossian","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekah","family":"Peacock","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Perez","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Ricketts","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benji","family":"Riggan","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherry","family":"Riser","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genie","family":"Roosevelt","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustapha","family":"Saheed","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Shy","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Simpson","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Solis","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Toerper","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Trent","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Trest","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Triplett","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Unsworth","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Vogel","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sommer","family":"Walker","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Waltrous","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Watson","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wilson","sequence":"additional","affiliation":[{"name":"for the DETECT Hep C Trial Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"key":"ioi260061r1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.02.008","article-title":"\u201cTowards eliminating viral hepatitis\u201d: examining the productive capacity and constitutive effects of global policy on hepatitis C elimination.","volume":"80","author":"Lancaster","year":"2020","journal-title":"Int J Drug Policy"},{"issue":"6","key":"ioi260061r2","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/jvh.13672","article-title":"Determining the lower limit of detection required for HCV viral load assay for test of cure following direct-acting antiviral-based treatment regimens: evidence from a global data set.","volume":"29","author":"Morgan","year":"2022","journal-title":"J Viral Hepat"},{"issue":"2","key":"ioi260061r3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6902a1","article-title":"CDC recommendations for hepatitis C screening among adults: US, 2020.","volume":"69","author":"Schillie","year":"2020","journal-title":"MMWR Recomm Rep"},{"issue":"6","key":"ioi260061r4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1001\/jama.2025.10563","article-title":"Hepatitis C screening in emergency departments: the DETECT Hep C randomized clinical trial.","volume":"334","author":"Haukoos","year":"2025","journal-title":"JAMA"},{"key":"ioi260061r5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/ciad319","article-title":"Hepatitis C guidance 2023 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection.","author":"Bhattacharya","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"4","key":"ioi260061r7","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/cid\/ciy098","article-title":"Population-level outcomes and cost-effectiveness of expanding the recommendation for age-based hepatitis C testing in the US.","volume":"67","author":"Barocas","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ioi260061r8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.annemergmed.2015.08.002","article-title":"Hepatitis C virus screening: an important public health opportunity for US emergency departments.","volume":"67","author":"Galbraith","year":"2016","journal-title":"Ann Emerg Med"},{"issue":"9","key":"ioi260061r9","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1093\/cid\/ciw073","article-title":"Prevalence of diagnosed and undiagnosed hepatitis C in a Midwestern urban emergency department.","volume":"62","author":"Lyons","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"ioi260061r10","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s13063-022-06265-1","article-title":"The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Screening Trial: rationale and design of a multicenter pragmatic randomized clinical trial of hepatitis C screening in emergency departments.","volume":"23","author":"Haukoos","year":"2022","journal-title":"Trials"},{"issue":"5","key":"ioi260061r11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097317","article-title":"The hepatitis C cascade of care: identifying priorities to improve clinical outcomes.","volume":"9","author":"Linas","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"ioi260061r12","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s11606-020-05701-9","article-title":"HCV testing and treatment in a national sample of US federally qualified health centers during the opioid epidemic.","volume":"35","author":"Assoumou","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"2","key":"ioi260061r14","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/hep.30501","article-title":"The hepatitis C virus care continuum: linkage to hepatitis C virus care and treatment among patients at an urban health network, Philadelphia, PA.","volume":"70","author":"Coyle","year":"2019","journal-title":"Hepatology"},{"issue":"6","key":"ioi260061r15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/jvh.12506","article-title":"Disparate access to treatment regimens in chronic hepatitis C patients: data from the TRIO network.","volume":"23","author":"Younossi","year":"2016","journal-title":"J Viral Hepat"},{"issue":"4","key":"ioi260061r17","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1056\/NEJMoa1702417","article-title":"Glecaprevir-pibrentasvir for 8 or 12 weeks in HCV genotype 1 or 3 infection.","volume":"378","author":"Zeuzem","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"ioi260061r18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/0272989X07311753","article-title":"Quality-of-life tradeoffs for hepatitis C treatment: do patients and providers agree?","volume":"28","author":"Schackman","year":"2008","journal-title":"Med Decis Making"},{"issue":"6","key":"ioi260061r20","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1111\/add.12863","article-title":"Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006-2010.","volume":"110","author":"Evans","year":"2015","journal-title":"Addiction"},{"issue":"4","key":"ioi260061r21","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/01.qai.0000186391.49205.3b","article-title":"Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility.","volume":"41","author":"Neaigus","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ioi260061r22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.drugalcdep.2014.03.029","article-title":"Characterizing longitudinal health state transitions among heroin, cocaine, and methamphetamine users.","volume":"140","author":"Nosyk","year":"2014","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"ioi260061r23","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1093\/infdis\/jiv220","article-title":"Hepatitis C virus reinfection and spontaneous clearance of reinfection: the InC3 study.","volume":"212","author":"Sacks-Davis","year":"2015","journal-title":"J Infect Dis"},{"issue":"34","key":"ioi260061r24","doi-asserted-by":"publisher","first-page":"7824","DOI":"10.3748\/wjg.v22.i34.7824","article-title":"Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes.","volume":"22","author":"Petruzziello","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"11","key":"ioi260061r25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-027491","article-title":"Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis update.","volume":"9","author":"Erman","year":"2019","journal-title":"BMJ Open"},{"issue":"3","key":"ioi260061r26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/cid\/civ860","article-title":"All-cause mortality and progression risks to hepatic decompensation and hepatocellular carcinoma in patients infected with hepatitis C virus.","volume":"62","author":"Xu","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"5","key":"ioi260061r27","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/ajg.2009.31","article-title":"Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study.","volume":"104","author":"Bruno","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"24","key":"ioi260061r28","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1001\/jama.2012.144878","article-title":"Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.","volume":"308","author":"van der Meer","year":"2012","journal-title":"JAMA"},{"issue":"2","key":"ioi260061r29","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s40121-021-00441-7","article-title":"Comparison of the prognosis of decompensated cirrhosis in patients with and without eradication of hepatitis C virus.","volume":"10","author":"Kumada","year":"2021","journal-title":"Infect Dis Ther"},{"key":"ioi260061r30","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.drugalcdep.2014.10.025","article-title":"Trends in use of health care and HIV prevention services for persons who inject drugs in San Francisco: results from National HIV Behavioral Surveillance 2005-2012.","volume":"146","author":"Coffin","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"ioi260061r31","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1016\/j.amepre.2022.03.010","article-title":"Medicaid hepatitis C Virus treatment policies: impact on testing and treatment in the commercially insured.","volume":"63","author":"Epstein","year":"2022","journal-title":"Am J Prev Med"},{"issue":"1","key":"ioi260061r32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies.","volume":"13","author":"Micallef","year":"2006","journal-title":"J Viral Hepat"},{"issue":"1","key":"ioi260061r34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-158-1-201301010-00003","article-title":"Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal.","volume":"158","author":"Coffin","year":"2013","journal-title":"Ann Intern Med"},{"issue":"5","key":"ioi260061r35","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/PHH.0000000000000514","article-title":"Can emergency department, hospital discharge, and death data be used to monitor burden of drug overdose in Rhode Island?","volume":"23","author":"Jiang","year":"2017","journal-title":"J Public Health Manag Pract"},{"issue":"11","key":"ioi260061r36","first-page":"526","article-title":"Cost of pharmacotherapy for opioid use disorders following inpatient detoxification.","volume":"24","author":"McCollister","year":"2018","journal-title":"Am J Manag Care"},{"issue":"2","key":"ioi260061r37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.7326\/M18-0227","article-title":"Cost-effectiveness of buprenorphine-naloxone versus extended-release naltrexone to prevent opioid relapse.","volume":"170","author":"Murphy","year":"2019","journal-title":"Ann Intern Med"},{"issue":"7","key":"ioi260061r39","doi-asserted-by":"publisher","first-page":"531","DOI":"10.18553\/jmcp.2011.17.7.531","article-title":"All-cause and incremental per patient per year cost associated with chronic hepatitis C virus and associated liver complications in the US: a managed care perspective.","volume":"17","author":"McAdam-Marx","year":"2011","journal-title":"J Manag Care Pharm"},{"issue":"2","key":"ioi260061r40","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1097\/MCG.0b013e3181e12c09","article-title":"Direct economic burden of chronic hepatitis C virus in a US managed care population.","volume":"45","author":"Davis","year":"2011","journal-title":"J Clin Gastroenterol"},{"issue":"4","key":"ioi260061r41","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/add.13219","article-title":"Measuring benefits of opioid misuse treatment for economic evaluation: health-related quality of life of opioid-dependent individuals and their spouses as assessed by a sample of the US population.","volume":"111","author":"Wittenberg","year":"2016","journal-title":"Addiction"},{"issue":"1","key":"ioi260061r42","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jval.2019.07.005","article-title":"A systematic review and meta-analysis of health utilities in patients with chronic hepatitis C.","volume":"23","author":"Saeed","year":"2020","journal-title":"Value Health"},{"issue":"15","key":"ioi260061r44","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1001\/jama.2023.1792","article-title":"Cost-effectiveness thresholds used by study authors, 1990-2021.","volume":"329","author":"Neumann","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"ioi260061r45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.7326\/M20-1392","article-title":"A health opportunity cost threshold for cost-effectiveness analysis in the US.","volume":"174","author":"Vanness","year":"2021","journal-title":"Ann Intern Med"},{"issue":"10","key":"ioi260061r46","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1001\/jama.2019.22313","article-title":"Universal screening for hepatitis C virus infection: a step toward elimination.","volume":"323","author":"Graham","year":"2020","journal-title":"JAMA"},{"issue":"1","key":"ioi260061r47","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1186\/s12879-017-2779-9","article-title":"Economic evaluation of HCV testing approaches in low- and middle-income countries.","volume":"17","author":"Morgan","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"1","key":"ioi260061r48","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s40273-021-01094-7","article-title":"Incorporating equity concerns in cost-effectiveness analyses: a systematic literature review.","volume":"40","author":"Ward","year":"2022","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"ioi260061r49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11606-021-06738-0","article-title":"Racial\/ethnic differences in emergency department utilization and experience.","volume":"37","author":"Parast","year":"2022","journal-title":"J Gen Intern Med"},{"key":"ioi260061r43","doi-asserted-by":"crossref","DOI":"10.1093\/acprof:oso\/9780190492939.001.0001","volume-title":"Cost-Effectiveness in Health and Medicine","author":"Neumann","year":"2016","edition":"2nd ed"},{"key":"ioi260061r6","unstructured":"CDC. Clinical screening and diagnosis for hepatitis C. Accessed May 8, 2025. https:\/\/www.cdc.gov\/hepatitis-c\/hcp\/diagnosis-testing\/index.html"},{"key":"ioi260061r13","unstructured":"Centers for Medicare and Medicaid Services. Clinical laboratory fee schedule. Accessed May 9, 2025. https:\/\/www.cms.gov\/medicare\/payment\/fee-schedules\/clinical-laboratory-fee-schedule-clfs"},{"key":"ioi260061r16","unstructured":"US Department of Veteran Affairs Office of Procurement, Acquisition, and Logistics. Federal supply schedule service. Accessed May 9, 2025. https:\/\/department.va.gov\/procurement-acquisition-and-logistics\/national-acquisition-center\/federal-supply-schedule-service"},{"key":"ioi260061r19","unstructured":"Social Security Administration. Actuarial life table. Accessed February 12, 2025. https:\/\/www.ssa.gov\/oact\/STATS\/table4c6.html"},{"key":"ioi260061r33","unstructured":"Agency for Healthcare Research and Quality. Medical expenditure panel survey: 2020 full year consolidated data file. Accessed July 11, 2025. https:\/\/meps.ahrq.gov\/mepsweb\/data_stats\/download_data_files.jsp"},{"key":"ioi260061r38","unstructured":"National Institute on Drug Abuse. Medications for opioid use disorder. Accessed February 12, 2025. https:\/\/nida.nih.gov\/research-topics\/medications-opioid-use-disorder"}],"container-title":["JAMA Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/articlepdf\/2855588\/jamainternal_czoty_2026_oi_260061_1792003511.89926.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:30:24Z","timestamp":1792423824000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/fullarticle\/2855588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,19]]},"references-count":49,"URL":"https:\/\/doi.org\/10.1001\/jamainternmed.2026.5163","relation":{},"ISSN":["2168-6106"],"issn-type":[{"value":"2168-6106","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,19]]}}}